Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
Kendall B. E. Moore, Ta-Jung Hung, Jessica S. Fortin
Drug Discovery Today (2023) Vol. 28, Iss. 3, pp. 103487-103487
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Jessica R. Cohen, Annette Mathew, Kirk D. Dourvetakis, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 511-511
Open Access | Times Cited: 25
Inhibitory effect of Dendrobium officinale polysaccharide on oxidative damage of glial cells in aging mice by regulating gut microbiota
Lei Xu, Xiaoxiong Zeng, Yanan Liu, et al.
International Journal of Biological Macromolecules (2023) Vol. 247, pp. 125787-125787
Closed Access | Times Cited: 21
Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches
Amirreza Gholami
Neuroscience Letters (2023) Vol. 817, pp. 137532-137532
Closed Access | Times Cited: 21
Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Enjie Liu, Yao Zhang, Jian–Zhi Wang
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy
Yao-Bo Li, Qiang Fu, Mei Guo, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Navigating the Maze of Alzheimer’s disease by exploring BACE1: Discovery, current scenario, and future prospects
Faiza Iram, Mohammad Shahid, Jaoud Ansari, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102342-102342
Closed Access | Times Cited: 7
Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy
Emma Ortiz, Pedro Montes, Citlali Ekaterina Rodríguez-Pérez, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 128-128
Open Access
The potential link between the development of Alzheimer’s disease and osteoporosis
Fariha Nasme, Jyotirmaya Behera, Prisha Tyagi, et al.
Biogerontology (2025) Vol. 26, Iss. 1
Closed Access
Biomarker Identification for Alzheimer’s Disease Using a Multi-Filter Gene Selection Approach
Elnaz Pashaei, Elham Pashaei, Nizamettin Aydın
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1816-1816
Open Access
Natural products as potential therapeutic agents against microplastic-induced neurodegenerative disease
Melike Kücükkarapinar, Helmuth Reuter
Studies in natural products chemistry (2025), pp. 425-459
Closed Access
A Concise Review on Oxidative Stress-Mediated Ferroptosis and Cuproptosis in Alzheimer’s Disease
Xudong Huang
Cells (2023) Vol. 12, Iss. 10, pp. 1369-1369
Open Access | Times Cited: 14
Role of Cytoskeletal Elements in Regulation of Synaptic Functions: Implications Toward Alzheimer’s Disease and Phytochemicals-Based Interventions
Harkomal Verma, Sharanjot Kaur, Sukhchain Kaur, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 8320-8343
Closed Access | Times Cited: 2
Protein modification in neurodegenerative diseases
Shahin Ramazi, Maedeh Dadzadi, Mona Darvazi, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 2
The association between rs6859 in NECTIN2 gene and Alzheimer’s disease is partly mediated by pTau
Aravind Lathika Rajendrakumar, Konstantin G. Arbeev, Olivia Bagley, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Alzheimer's Disease: Status of Low‐Dimensional Nanotherapeutic Materials
Dongqing Huang, Wang Liao, Jun Li, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 4
Closed Access | Times Cited: 5
Black phosphorus nanosheets as therapeutic “garbage trucks” for the selective clearance of peripheral phosphorylated Tau proteins in Alzheimer’s disease
Rui Ma, Zilin Li, Yucheng Guan, et al.
Chemical Engineering Journal (2024) Vol. 486, pp. 150193-150193
Closed Access | Times Cited: 1
Exploring the effectiveness and safety profile of TAU protein antibodies as potential therapies for alzheimer's disease: a comprehensive review
Muhammad Essa, N. Zaheer Ahmed, Amanullah Kakar, et al.
(2024)
Open Access | Times Cited: 1
Behavioral neuroscience in zebrafish: unravelling the complexity of brain-behavior relationships
Sayed Mohammed Firdous, Sourav Pal, Sofia Khanam, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9295-9313
Closed Access | Times Cited: 1
Introduction to Alzheimer's Disease, Biomarkers, and the AI Revolution
Bancha Yingngam
Advances in medical technologies and clinical practice book series (2024), pp. 1-23
Closed Access | Times Cited: 1
Comprehending the Efficacy of Whitlock's Caffeine-Pincered Molecular Tweezer on β-Amyloid Aggregation
Madhusmita Devi, Sandip Paul
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 17, pp. 3202-3219
Closed Access | Times Cited: 1
Advances in natural polysaccharides in Alzheimer's disease and Parkinson's disease: Insights from the brain-gut axis
Yueqin Feng, Fengjin Hao
Trends in Food Science & Technology (2024) Vol. 153, pp. 104678-104678
Closed Access | Times Cited: 1
Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer’s Disease and Down Syndrome
Laurent Meijer, Emilie Chrétien, Denis Ravel
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S95-S113
Closed Access | Times Cited: 1
Navigating the Role and Approach of Gut Microbiota in Addressing Alzheimer's Disease Pathogenesis
Imrana Jazuli, Akeela Jazeel, Lakshmi Selvaratnam, et al.
Progress In Microbes & Molecular Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Atomic insights into the inhibition of R3 domain of tau protein by epigallocatechin gallate, quercetin and gallic acid
Jiaxing Tang, Ruiqing Sun, Jiaqian Wan, et al.
Biophysical Chemistry (2023) Vol. 305, pp. 107142-107142
Closed Access | Times Cited: 4
Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer’s disease
Mohd Adnan, Debarati DasGupta, Saleha Anwar, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top